Abstract:OBJECTIVE: Graves' disease (GD) is one of the most common autoimmune conditions, but the mechanisms underlying the associated induction of autoimmunity are not known. We explored the role of peripheral lymphocyte subpopulations in disease pathogenesis.METHODS: In total, 32 patients and 40 age- and sex-matched healthy controls were recruited in this study. Peripheral levels of T, B, NK, CD4<sup>+</sup> T, CD8<sup>+</sup> T, Th1, Th2, Th17, and Treg cells were measured using flow cytometry. For all patients, we compared all lymphocyte subpopulations between GD patients and healthy controls. Changes in patient lymphocyte subsets were compared before and after treatment.RESULTS: The absolute numbers of circulating Th17 cells (0.45 ± 1.16, p > 0.05) between GD patients and healthy controls were not significantly different. However, the percentage of Th17 cells was significantly increased (0.25 ± 0.11, p < 0.05). The absolute numbers and percentages of circulating Tregs in GD patients were significantly decreased compared with those in healthy participants (11.61 ± 2.75, p < 0.05). There was a significant difference in Treg absolute numbers between the untreated and drug-treated groups. Furthermore, we found that the Treg percentage in untreated patients (mean=4.78) was not significantly different from that in the drug-treated group (mean=4.81). In addition, circulating Treg absolute numbers in GD patients with exophthalmos were significantly lower than those in GD patients without exophthalmos (9.96 ± 4.16, p < 0.05). A similar trend was observed in GD patients with weight loss (11.97 ± 3.28, p < 0.05).CONCLUSION: GD pathogenesis was associated with a lower Treg population and an increased Th17/Treg ratio (T helper cell 17/ regulatory T cells). Th17 cells in this study were not related to the disease. Furthermore, anti-thyroid drug therapy improved immune-mediated system disorders. Finally, we found lower absolute numbers of circulating Tregs in GD patients with certain positive signs, such as exophthalmos and/or weight loss. Thus, immune changes are correlated with partial clinical manifestations.

Variation of CD4 + CD25 + regulatory T cells in patients with Graves' disease

Impairment of Regulatory Capacity of Cd4(+)Cd25(+) Regulatory T Cells Mediated by Dendritic Cell Polarization and Hyperthyroidism in Graves' Disease

The relationship between CD4~+ CD25~+ regulatory T cell and Graves' disease

Constitutive Changes in Circulating Follicular Helper T Cells and Their Subsets in Patients with Graves’ Disease

Expression of CD1s in Peripheral Blood Lymphocytes and Mononuclear Cells in Grave's Disease Patients

Significance of Th17 cells in the peripheral blood of patients with Graves disease

The Change of CD4+CD25+Foxp3+regulatory T Cells in Peripheral Blood of Patients with Graves Disease Treated by Iodine-131

Decrease in Proportion of Cd19(+)Cd24(Hi)Cd27(+) B Cells and Impairment of Their Suppressive Function in Graves' Disease

Absolute reduction in peripheral regulatory T cells in patients with Graves’ disease and post-treatment recovery

Expansion of Inflammatory Monocytes in Periphery and Infiltrated into Thyroid Tissue in Graves' Disease.

The CD14++CD16+ monocyte subset is expanded and controls Th1 cell development in Graves' disease

CD11c+ B Cells Participate in the Pathogenesis of Graves’ Disease by Secreting Thyroid Autoantibodies and Cytokines

Elevated Interleukin-36α and CD4+IL-36α+T Cells Are Involved in the Pathogenesis of Graves' Disease.

Expression of CTLA-4 and CD40L on periperal T lymphocytes in autoimmune thyroid disease

MiR-363-5p modulates regulatory T cells through STAT4-HSPB1-Notch1 axis and is associated with the immunological abnormality in Graves' disease

Regulatory T Cells in the Pathogenesis of Graves' Disease

The Changes of the Peripheral Blood Dendritic Cells and Some Related Cytokines in Graves’ Disease Patients

Decreased Treg Cell and TCR Expansion Are Involved in Long-Lasting Graves’ Disease

Elevated Expression and Activation of GPR15 in Immune Cells in Graves' Disease

Plasmacytoid dendritic cells,interferon-α and CD4~+ CD25~+ regulatory T cells in immunopathogenic mechanism of Graves disease

Differential Microrna Expression in Peripheral Blood Mononuclear Cells from Graves' Disease Patients